Virupaksha Organics Increases Stake in Oxygenta Pharma to 55.90%

Oxygenta Pharmaceutical Limited has seen an increase in Virupaksha Organics Limited's stake through additional equity share acquisitions in the open market. Virupaksha Organics acquired 1,95,885 equity shares of Oxygenta Pharmaceutical Limited, raising its shareholding from 55.37% to 55.90%.

Transaction Details

The share acquisition was executed through open market purchases, with Virupaksha Organics acting as the promoter of Oxygenta Pharmaceutical Limited. The transaction details are summarized below:

Parameter	Details
Shares Acquired	1,95,885 equity shares
Mode of Acquisition	Open market purchase
Percentage Acquired	0.53%

Shareholding Pattern Changes

The acquisition has resulted in a marginal increase in Virupaksha Organics' stake in Oxygenta Pharmaceutical. The shareholding pattern before and after the transaction shows the following changes:

Shareholding Status	Before Acquisition	After Acquisition	Change
Percentage Holding	55.37%	55.90%	+0.53%

Market Implications

This acquisition reinforces Virupaksha Organics' commitment to maintaining its controlling stake in Oxygenta Pharmaceutical Limited. The transaction was conducted through regular market channels, indicating standard investment activity rather than any strategic restructuring. The modest increase in shareholding percentage suggests routine portfolio management by the promoter entity.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.82%	-8.13%	-11.02%	-54.00%	-38.51%	+154.47%

Oxygenta Pharmaceutical Limited has successfully completed the reclassification of four promoter group shareholders to public category following overwhelming shareholder approval through postal ballot. The company received regulatory clearance from BSE Limited and confirmed compliance with all SEBI requirements under Regulation 31A.

Postal Ballot Results and Shareholder Approval

The postal ballot conducted from November 12 to December 11 achieved remarkable shareholder participation with 99.98% approval for the promoter reclassification proposal. Ms. Kumkum Bajaj, Company Secretary and Compliance Officer, declared the results with Ms. Aakanksha Sachin Dubey serving as the appointed Scrutinizer.

Voting Category:	Total Shares	Votes in Favor	Votes Against	Approval Rate
Promoter/Promoter Group:	20,477,458	20,477,458	0	100.00%
Public-Non Institutions:	9,785	6,333	3,452	64.72%
Total:	20,487,243	20,483,791	3,452	99.98%

Reclassified Shareholders Details

Four promoter group shareholders successfully transitioned to public category status, collectively holding 9.42 lakh shares representing 2.55% of the company's paid-up equity capital. The reclassification received BSE's no-objection certificate dated October 16 under reference number LIST/COMP/KR/514/2025-26.

Shareholder Name:	Shares Held	Category Change
Mr. Sai Sudhakar Vankineni:	30,000	Promoter to Public
Ms. Snigdha Vankineni:	5,43,000	Promoter to Public
Mr. Sumanth Simha Vankineni:	3,43,700	Promoter to Public
Mrs. Jhansi Rani Vankineni:	26,000	Promoter to Public
Total Shares:	9,42,700	2.55% of Equity

Regulatory Compliance and Process Timeline

The reclassification process commenced with applications received on August 19 from the four shareholders seeking status change from promoter group to public category. The Board of Directors approved the proposal on August 25 and subsequently obtained BSE's regulatory clearance.

Process Milestone:	Date	Details
Application Received:	August 19	Four shareholders applied for reclassification
Board Approval:	August 25	Directors approved the reclassification process
BSE Application:	August 29	Submitted to stock exchange for approval
BSE No-Objection:	October 16	Regulatory clearance obtained
Postal Ballot Period:	November 12 - December 11	Shareholder voting conducted
Results Declaration:	December 11	Final approval with 99.98% majority

SEBI Regulation 31A Compliance

All reclassified shareholders confirmed compliance with SEBI Regulation 31A requirements, including holding less than 10% equity capital, exercising no control over company affairs, having no special rights through formal arrangements, and maintaining no Board representation. The outgoing promoters also confirmed they are neither willful defaulters nor fugitive economic offenders.

Corporate Governance Impact

Mr. Balasubba Reddy Mamilla, Whole-time Director, confirmed that the company remains compliant with minimum public shareholding requirements under Regulation 38 of SEBI LODR Regulations. The successful reclassification strengthens Oxygenta Pharmaceutical's corporate governance framework while maintaining regulatory compliance across all statutory requirements.

The company has completed all necessary intimations to stock exchanges and regulatory authorities within prescribed timelines, marking the effective transition of the four shareholders from promoter group to public category status.